Ninety screening for cancers endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells Breast Lymph Nodes Prostate Myometrium

Organisms2

Mice, Nude Mice, SCID

Diseases69

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Ovarian Neoplasms Neoplasms Pancreatic Neoplasms Breast Neoplasms Neoplasm Invasiveness Lung Neoplasms Prostatic Neoplasms Stomach Neoplasms Endometrial Hyperplasia Colonic Neoplasms Neoplasm Metastasis Uterine Neoplasms Carcinoma Adenocarcinoma Genetic Predisposition to Disease Genital Neoplasms, Female Neoplasm Recurrence, Local Uterine Cervical Neoplasms Cystadenocarcinoma, Serous Neoplasms, Multiple Primary Neoplasms, Second Primary Colorectal Neoplasms Disease Progression Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms Carcinoma, Squamous Cell Skin Neoplasms Adenocarcinoma, Clear Cell Liver Neoplasms Cell Transformation, Neoplastic Carcinoma, Non-Small-Cell Lung Cystadenocarcinoma, Papillary Neoplasms, Hormone-Dependent Thyroid Neoplasms Rectal Neoplasms Kidney Neoplasms Adenocarcinoma, Mucinous Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Radiation-Induced Neoplasms, Glandular and Epithelial Precancerous Conditions Gastrointestinal Neoplasms Bone Neoplasms Mouth Neoplasms Esophageal Neoplasms Adenocarcinoma, Papillary Head and Neck Neoplasms Carcinoma, Papillary Neoplasms, Experimental Carcinoma, Pancreatic Ductal Microsatellite Instability Neovascularization, Pathologic Testicular Neoplasms Mixed Tumor, Mullerian Adenoma Peritoneal Neoplasms Carcinoma, Small Cell Vaginal Neoplasms Obesity Mammary Neoplasms, Experimental Carcinoma, Adenosquamous Pharyngeal Neoplasms Carcinosarcoma Uterine Hemorrhage Disease Models, Animal Intestinal Neoplasms

Chemicals and Drugs49

Neoplasm Proteins Tumor Markers, Biological Tamoxifen DNA, Neoplasm Receptors, Estrogen Antineoplastic Agents Estrogens Receptors, Progesterone Cancer Vaccines Antineoplastic Agents, Hormonal RNA, Messenger Antigens, Neoplasm Progestins Receptor, erbB-2 RNA, Small Interfering Tumor Suppressor Protein p53 Estrogen Antagonists PTEN Phosphohydrolase Estrogen Receptor alpha Cisplatin Tumor Suppressor Proteins Paclitaxel Prostate-Specific Antigen Contraceptives, Oral Anticarcinogenic Agents Nuclear Proteins Antineoplastic Agents, Phytogenic RNA, Neoplasm DNA-Binding Proteins MicroRNAs Estrogen Receptor Modulators Fluorouracil Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Antibodies, Monoclonal Selective Estrogen Receptor Modulators Receptor, Epidermal Growth Factor Adaptor Proteins, Signal Transducing MutS Homolog 2 Protein Transcription Factors Receptors, Androgen Carcinogens CA-125 Antigen Estradiol TOR Serine-Threonine Kinases Ki-67 Antigen Deoxycytidine Androgens Antimetabolites, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Early Detection of Cancer Neoplasm Staging Prognosis Risk Factors Risk Retrospective Studies Prospective Studies Survival Rate Survival Analysis Follow-Up Studies Hysterectomy Odds Ratio Registries Reverse Transcriptase Polymerase Chain Reaction Immunohistochemistry Risk Assessment Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Incidence Disease-Free Survival Gene Expression Profiling Sensitivity and Specificity Xenograft Model Antitumor Assays Neoplasm Grading Neoplasm Transplantation Blotting, Western Questionnaires Combined Modality Therapy Treatment Outcome Estrogen Replacement Therapy Logistic Models Cohort Studies Chemotherapy, Adjuvant SEER Program Kaplan-Meier Estimate Polymerase Chain Reaction Multivariate Analysis Oligonucleotide Array Sequence Analysis Immunoenzyme Techniques Confidence Intervals Predictive Value of Tests Salpingectomy Transplantation, Heterologous Lymph Node Excision Molecular Targeted Therapy Body Mass Index Reproducibility of Results Drug Screening Assays, Antitumor Tissue Array Analysis Clinical Trials as Topic Tumor Burden Neoplasms, Experimental Radiotherapy, Adjuvant Radiotherapy Biopsy Transfection Mammography Hormone Replacement Therapy Genetic Testing DNA Mutational Analysis Drug Administration Schedule Gene Knockdown Techniques Flow Cytometry Models, Biological Obesity Tomography, X-Ray Computed Chi-Square Distribution Mammary Neoplasms, Experimental Disease Models, Animal Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Odds Ratio Postmenopause Mutation Drug Resistance, Neoplasm Genotype DNA Methylation Sensitivity and Specificity Cell Proliferation Germ-Line Mutation Polymorphism, Genetic Apoptosis Cell Growth Processes Cell Survival Gene Silencing Down-Regulation Cell Division Menopause Dose-Response Relationship, Drug Body Mass Index Cell Cycle Cell Movement Genes, Tumor Suppressor Time Factors Promoter Regions, Genetic Microsatellite Repeats Premenopause Diet Microsatellite Instability Signal Transduction Base Sequence Genes, Neoplasm Transfection Alleles Genes, BRCA1 Up-Regulation RNA Interference Phenotype Parity Genes, p53 Gene Expression Phosphorylation Obesity Chi-Square Distribution Loss of Heterozygosity Epithelial-Mesenchymal Transition DNA Mismatch Repair Drug Synergism

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care34

Risk Factors Risk Retrospective Studies Prospective Studies Survival Rate Survival Analysis Follow-Up Studies Odds Ratio Registries Risk Assessment Age Factors Case-Control Studies Incidence Disease-Free Survival Sensitivity and Specificity Questionnaires Treatment Outcome Logistic Models National Cancer Institute (U.S.)Cohort Studies SEER Program Kaplan-Meier Estimate Multivariate Analysis Confidence Intervals Predictive Value of Tests Body Mass Index Reproducibility of Results Clinical Trials as Topic Genetic Testing Parity Age Distribution American Cancer Society Chi-Square Distribution Confounding Factors (Epidemiology)

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Early Detection of Cancer Ovarian Neoplasms Neoplasms Pancreatic Neoplasms Breast Neoplasms Neoplasm Invasiveness Lung Neoplasms Neoplasm Staging Prostatic Neoplasms Prognosis Gene Expression Regulation, Neoplastic Stomach Neoplasms Endometrial Hyperplasia Colonic Neoplasms Neoplasm Metastasis Uterine Neoplasms Risk Factors Neoplasm Proteins Tumor Markers, Biological Risk Retrospective Studies Carcinoma Adenocarcinoma Genetic Predisposition to Disease Cell Line, Tumor Prospective Studies Survival Rate Survival Analysis Follow-Up Studies Mice, Nude Hysterectomy Tamoxifen Endometrium DNA, Neoplasm Genital Neoplasms, Female Neoplasm Recurrence, Local Uterine Cervical Neoplasms Cystadenocarcinoma, Serous Odds Ratio Neoplasms, Multiple Primary Neoplasms, Second Primary Colorectal Neoplasms Receptors, Estrogen Registries Antineoplastic Agents Estrogens Postmenopause Reverse Transcriptase Polymerase Chain Reaction Immunohistochemistry Risk Assessment Receptors, Progesterone Mutation Cancer Vaccines Disease Progression Age Factors United States Antineoplastic Agents, Hormonal Antineoplastic Combined Chemotherapy Protocols Colorectal Neoplasms, Hereditary Nonpolyposis Case-Control Studies Urinary Bladder Neoplasms Carcinoma, Squamous Cell Skin Neoplasms RNA, Messenger Drug Resistance, Neoplasm Incidence Disease-Free Survival Genotype Gene Expression Profiling DNA Methylation Adenocarcinoma, Clear Cell Sensitivity and Specificity Xenograft Model Antitumor Assays Liver Neoplasms Neoplasm Grading Neoplasm Transplantation Blotting, Western Antigens, Neoplasm Questionnaires Cell Transformation, Neoplastic Combined Modality Therapy Treatment Outcome Estrogen Replacement Therapy Carcinoma, Non-Small-Cell Lung Cystadenocarcinoma, Papillary Progestins Logistic Models Cell Proliferation Neoplasms, Hormone-Dependent Survivors National Cancer Institute (U.S.)Thyroid Neoplasms Receptor, erbB-2 Germ-Line Mutation Rectal Neoplasms Cohort Studies Kidney Neoplasms

No FAQ available that match "ninety screening for cancers endometrial cancer vulvar neoplasms"